publication date: Jan. 23, 2015

Lancaster Leaves Moffitt To Join Myriad Genetics


JOHNATHAN LANCASTER joined Myriad Genetics as vice president of medical affairs for oncology in Myriad Genetic Laboratories, effective Feb. 9.

Lancaster will provide medical and scientific leadership across Myriad’s expanding portfolio of molecular and companion diagnostic products and services for oncology.

Over the past 12 years, he held leadership positions at Moffitt Cancer Center, including president of Moffitt Medical Group, deputy physician-in-chief, director of the Center for Women’s Oncology, and chair of the Department of Women’s Oncology. Before Moffitt, Lancaster was a medical director of the Gynecologic Dysplasia Clinic at Duke University Medical Center, where he also completed his residency and fellowship training.


SUE BIGGINS was awarded the Edward Novitski Prize by the Genetics Society of America.

Biggins is a researcher at Fred Hutchinson Cancer Research Center. The award recognizes her research on the molecular mechanisms of chromosome segregation, a process essential for cell division and frequently impaired in cancer.

Biggins has been studying the kinetochore, a molecular machine that mediates chromosome segregation during cell division, for the last 20 years. Before her work, kinetochores had been challenging to isolate and investigate due to their complex, dynamic nature. Biggins tackled this problem in the budding yeast Saccharomyces cerevisiae, in which the chromosome segregation machinery is a simplified version of that found in humans. She accomplished the first isolation of the kinetochore in any organism by developing an elegant one-step method.

Biggins has been a GSA member for 15 years, is an associate editor of the society’s flagship journal Genetics, and has served on the organizing committee of GSA’s biannual Yeast Genetics … Continue reading 41-03 Lancaster Leaves Moffitt To Join Myriad Genetics

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.